Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 3
1978 3
1979 1
1981 3
1982 2
1984 5
1985 4
1986 1
1987 5
1988 4
1989 8
1990 4
1991 3
1992 5
1993 3
1994 12
1995 11
1996 14
1997 17
1998 9
1999 19
2000 23
2001 23
2002 12
2003 23
2004 14
2005 10
2006 10
2007 10
2008 14
2009 13
2010 11
2011 15
2012 15
2013 14
2014 9
2015 20
2016 14
2017 16
2018 8
2019 15
2020 24
2021 26
2022 28
2023 34
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

502 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. Bikdeli B, et al. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. J Am Coll Cardiol. 2020. PMID: 32311448 Free PMC article. Review.
In addition, many patients receiving antithrombotic therapy for thrombotic disease may develop COVID-19, which can have implications for choice, dosing, and laboratory monitoring of antithrombotic therapy. Moreover, during a time with much focus on COVID-19, it is c …
In addition, many patients receiving antithrombotic therapy for thrombotic disease may develop COVID-19, which can have implic …
Genetic aspects of thrombotic disease.
García de Frutos P, Zöller B. García de Frutos P, et al. Thromb Haemost. 2015 Nov;114(5):883-4. doi: 10.1160/TH15-10-0774. Epub 2015 Oct 15. Thromb Haemost. 2015. PMID: 26467566 No abstract available.
Behcet's Syndrome.
Dalvi SR, Yildirim R, Yazici Y. Dalvi SR, et al. Drugs. 2012 Dec 3;72(17):2223-41. doi: 10.2165/11641370-000000000-00000. Drugs. 2012. PMID: 23153327 Review.
Finally, we conclude with treatment strategies for the common manifestations of BS along with a discussion of the management of thrombotic disease in these patients....
Finally, we conclude with treatment strategies for the common manifestations of BS along with a discussion of the management of thromboti …
Thrombotic triad in microgravity.
Elahi MM, Witt AN, Pryzdial ELG, McBeth PB. Elahi MM, et al. Thromb Res. 2024 Jan;233:82-87. doi: 10.1016/j.thromres.2023.11.020. Epub 2023 Nov 22. Thromb Res. 2024. PMID: 38029549 Review.
Thrombotic disease may be an underdiagnosed condition of prolonged exposure to microgravity and yet the underlying factors remain poorly defined. ...Observations in space as well as clinical and in vitro microgravity studies on Earth, where experiments are designed …
Thrombotic disease may be an underdiagnosed condition of prolonged exposure to microgravity and yet the underlying factors rem …
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
Cohen H, Sayar Z, Efthymiou M, Gaspar P, Richards T, Isenberg D. Cohen H, et al. Lancet Haematol. 2020 Aug;7(8):e613-e623. doi: 10.1016/S2352-3026(20)30116-2. Lancet Haematol. 2020. PMID: 32735839 Review.
Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral anticoagulation treatment and its management is a major challenge given the serious nature of the thrombotic disease observed, whic …
Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral antic …
Hyperhomocysteinaemia.
Perry DJ. Perry DJ. Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):451-77. doi: 10.1053/beha.1999.0036. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10856981 Review.
In contrast, moderate hyperhomocysteinaemia is associated with an increased risk of both arterial and venous thrombotic disease but no other abnormalities. This increased risk appears to be independent of other conventional risk factors. ...
In contrast, moderate hyperhomocysteinaemia is associated with an increased risk of both arterial and venous thrombotic disease …
Microparticles and thrombotic disease.
Davizon P, López JA. Davizon P, et al. Curr Opin Hematol. 2009 Sep;16(5):334-41. doi: 10.1097/MOH.0b013e32832ea49c. Curr Opin Hematol. 2009. PMID: 19606028 Review.
Fibrin(ogen) and thrombotic disease.
Ariëns RA. Ariëns RA. J Thromb Haemost. 2013 Jun;11 Suppl 1:294-305. doi: 10.1111/jth.12229. J Thromb Haemost. 2013. PMID: 23809133 Free article. Review.
Studies of fibrin formation under flow, interactions of fibrin with blood cells, the mechanical properties of the fibrin clot, and nanoscale/molecular characterization of fibrin formation are likely to expose new causal mechanisms for the role of fibrin in thrombotic di …
Studies of fibrin formation under flow, interactions of fibrin with blood cells, the mechanical properties of the fibrin clot, and nanoscale …
Hyperhomocysteinemia and thrombosis.
Guba SC, Fonseca V, Fink LM. Guba SC, et al. Semin Thromb Hemost. 1999;25(3):291-309. doi: 10.1055/s-2007-994932. Semin Thromb Hemost. 1999. PMID: 10443960 Review.
Homocysteine has been identified as an independent risk factor for atherosclerotic and thrombotic disease. Both arterial (cerebrovascular, carotid, coronary, and peripheral arterial) and veno-occlusive disease, jointly termed vascular occlusive disease (VOD) in this …
Homocysteine has been identified as an independent risk factor for atherosclerotic and thrombotic disease. Both arterial (cere …
COVID-19: Not a thrombotic disease but a thromboinflammatory disease.
He S, Blombäck M, Wallén H. He S, et al. Ups J Med Sci. 2024 Jan 22;129. doi: 10.48101/ujms.v129.9863. eCollection 2024. Ups J Med Sci. 2024. PMID: 38327640 Free PMC article. Review.
This study aims to reaffirm our previous hypothesis that COVID-19 is fundamentally a thrombotic disease. To accomplish this, we have undertaken an extensive literature review focused on assessing the comprehensive impact of COVID-19 on the entire hemostatic system. …
This study aims to reaffirm our previous hypothesis that COVID-19 is fundamentally a thrombotic disease. To accomplish this, w …
502 results